Puma Biotechnology (PBYI) Profit After Tax (2010 - 2026)

Puma Biotechnology has reported Profit After Tax for 17 years, with the latest figure at -$3.8 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax fell 227.77% year-over-year to -$3.8 million; the trailing twelve-month figure through Mar 2026 stood at $24.3 million (down 36.1% YoY), and the FY2025 full-year result was $31.1 million, up 2.71% from the prior year.
• Profit After Tax for Q1 2026 stood at -$3.8 million, down from $13.4 million in the prior quarter.
• The five-year high for Profit After Tax was $20.3 million in Q3 2024, with the low at -$5.6 million in Q4 2022.
• Historically, Profit After Tax has averaged $4.7 million across 5 years, with a median of $3.0 million in 2025.
• Annual changes were most pronounced in 2023 — Profit After Tax surged 1710.0% — and 2024, when it slumped 443.68%.
• Puma Biotechnology's Profit After Tax stood at -$5.6 million in 2022, then soared by 318.84% to $12.3 million in 2023, then jumped by 57.36% to $19.3 million in 2024, then plunged by 30.45% to $13.4 million in 2025, then slumped by 128.3% to -$3.8 million in 2026.
• The last three Profit After Tax figures came in at -$3.8 million (Q1 2026), $13.4 million (Q4 2025), and $8.8 million (Q3 2025), per Business Quant data.